{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:27Z","timestamp":1794047427994,"version":"4.8.0"},"reference-count":46,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"9","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Langerhans cell histiocytosis (LCH) is a potentially life-threatening inflammatory myeloid neoplasia linked to pediatric neurodegeneration, whereby transformed LCH cells form agglomerated lesions in various organs. Although MAP-kinase pathway mutations have been identified in LCH cells, the functional consequences of these mutations and the mechanisms that cause the pathogenic behavior of LCH cells are not well understood. In our study, we used an in vitro differentiation system and RNA-sequencing to compare monocyte-derived dendritic cells from LCH patients to those derived from healthy controls or patients with Crohn\u2019s disease, a non-histiocytic inflammatory disease. We observed that interferon-\u03b3 treatment exacerbated intrinsic differences between LCH patient and control cells, including strikingly increased endo- and exocytosis gene activity in LCH patients. We validated these transcriptional patterns in lesions and functionally confirmed that LCH cells exhibited increased endo- and exocytosis. Furthermore, RNA-sequencing of extracellular vesicles revealed the enrichment of pathological transcripts involved in cell adhesion, MAP-kinase pathway, vesicle trafficking and T-cell activation in LCH patients. Thus, we tested the effect of the LCH secretome on lymphocyte activity and found significant activation of NK cells. These findings implicate extracellular vesicles in the pathology of LCH for the first time, in line with their established roles in the formation of various other tumor niches. Thus, we describe novel traits of LCH patient cells and suggest a pathogenic mechanism of potential therapeutic and diagnostic importance.<\/jats:p>","DOI":"10.3324\/haematol.2022.282638","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T04:06:53Z","timestamp":1678939613000},"page":"2422-2434","source":"Crossref","is-referenced-by-count":1,"title":["Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells"],"prefix":"10.3324","volume":"108","author":[{"given":"Daniel W.","family":"Hagey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egle","family":"Kvedaraite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Akber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"G\u00f6rgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joman","family":"Javadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Von Bahr Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma Olsson","family":"\u00c5kefeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tova","family":"Hanneg\u00e5rd-Hamrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Arnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Dobra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"EL Andaloussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Inge","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Lourda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"51517","doi-asserted-by":"crossref","unstructured":"Allen CE, Merad M, McClain KL. Langerhans-cell histiocytosis. N Engl J Med. 2018; 379(9):856-868.","DOI":"10.1056\/NEJMra1607548"},{"key":"51518","doi-asserted-by":"crossref","unstructured":"Badalian-Very G, Vergilio JA, Degar BA. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010; 116(11):1919-1923.","DOI":"10.1182\/blood-2010-04-279083"},{"key":"51519","doi-asserted-by":"crossref","unstructured":"Sahm F, Capper D, Preusser M. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood. 2012; 120(12):e28-34.","DOI":"10.1182\/blood-2012-06-429597"},{"key":"51520","doi-asserted-by":"crossref","unstructured":"Zeng K, Wang Z, Ohshima K. BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis. Oncoimmunology. 2016; 5(7):e1185582.","DOI":"10.1080\/2162402X.2016.1185582"},{"key":"51521","doi-asserted-by":"crossref","unstructured":"Lourda M, Olsson-Akefeldt S, Gavhed D. Detection of IL-17A-producing peripheral blood monocytes in Langerhans cell histiocytosis patients. Clin Immunol. 2014; 153(1):112-122.","DOI":"10.1016\/j.clim.2014.04.004"},{"key":"51522","doi-asserted-by":"crossref","unstructured":"Oh Y, Morimoto A, Shioda Y. High serum osteopontin levels in pediatric patients with high risk Langerhans cell histiocytosis. Cytokine. 2014; 70(2):194-197.","DOI":"10.1016\/j.cyto.2014.07.002"},{"key":"51523","doi-asserted-by":"crossref","unstructured":"Lourda M, Olsson-Akefeldt S, Gavhed D. Adsorptive depletion of blood monocytes reduces the levels of circulating interleukin-17A in Langerhans cell histiocytosis. Blood. 2016; 128(9):1302-1305.","DOI":"10.1182\/blood-2016-03-708107"},{"key":"51524","doi-asserted-by":"crossref","unstructured":"Morimoto A, Oh Y, Nakamura S. Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis. Cytokine. 2017; 97:73-79.","DOI":"10.1016\/j.cyto.2017.05.026"},{"key":"51525","doi-asserted-by":"crossref","unstructured":"Andersson By U, Tani E, Andersson U, Henter JI. Tumor necrosis factor, interleukin 11, and leukemia inhibitory factor produced by Langerhans cells in Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 2004; 26(11):706-711.","DOI":"10.1097\/00043426-200411000-00004"},{"key":"51526","unstructured":"Kannourakis G, Abbas A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br J Cancer Suppl. 1994; 23:S37-40."},{"key":"51527","doi-asserted-by":"crossref","unstructured":"van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018; 19(4):213-228.","DOI":"10.1038\/nrm.2017.125"},{"key":"51528","doi-asserted-by":"crossref","unstructured":"Elsharkasy OM, Nordin JZ, Hagey DW. Extracellular vesicles as drug delivery systems: why and how?. Adv Drug Deliv Rev. 2020; 159:332-343.","DOI":"10.1016\/j.addr.2020.04.004"},{"key":"51529","doi-asserted-by":"crossref","unstructured":"Xu R, Rai A, Chen M. Extracellular vesicles in cancer -implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018; 15(10):617-638.","DOI":"10.1038\/s41571-018-0036-9"},{"key":"51530","doi-asserted-by":"crossref","unstructured":"Coury F, Annels N, Rivollier A. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med. 2008; 14(1):81-87.","DOI":"10.1038\/nm1694"},{"key":"51531","doi-asserted-by":"crossref","unstructured":"Bost JP, Saher O, Hagey D. Growth media conditions influence the secretion route and release levels of engineered extracellular vesicles. Adv Healthc Mater. 2022; 11(5):e2101658.","DOI":"10.1002\/adhm.202101658"},{"key":"51532","doi-asserted-by":"crossref","unstructured":"Hagey DW, Kordes M, Gorgens A. Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer. J Extracell Vesicles. 2021; 10(12):e12142.","DOI":"10.1002\/jev2.12142"},{"key":"51533","doi-asserted-by":"crossref","unstructured":"Olsson Akefeldt S, Maisse C, Belot A. Chemoresistance of human monocyte-derived dendritic cells is regulated by IL-17A. PLoS One. 2013; 8(2):e56865.","DOI":"10.1371\/journal.pone.0056865"},{"key":"51534","doi-asserted-by":"crossref","unstructured":"Tang-Huau TL, Segura E. Human in vivo-differentiated monocyte-derived dendritic cells. Semin Cell Dev Biol. 2019; 86:44-49.","DOI":"10.1016\/j.semcdb.2018.02.018"},{"key":"51535","doi-asserted-by":"crossref","unstructured":"Holter W, Ressmann G, Grois N. Normal monocyte-derived dendritic cell function in patients with Langerhans-cell-histiocytosis. Med Pediatr Oncol. 2002; 39(3):181-186.","DOI":"10.1002\/mpo.10129"},{"key":"51536","doi-asserted-by":"crossref","unstructured":"Allen CE, Li L, Peters TL. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010; 184(8):4557-4567.","DOI":"10.4049\/jimmunol.0902336"},{"key":"51537","doi-asserted-by":"crossref","unstructured":"Halbritter F, Farlik M, Schwentner R. Epigenomics and single-cell sequencing define a developmental hierarchy in Langerhans cell histiocytosis. Cancer Discov. 2019; 9(10):1406-1421.","DOI":"10.1158\/2159-8290.CD-19-0138"},{"key":"51538","doi-asserted-by":"crossref","unstructured":"Kaksonen M, Roux A. Mechanisms of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2018; 19(5):313-326.","DOI":"10.1038\/nrm.2017.132"},{"key":"51539","doi-asserted-by":"crossref","unstructured":"Johansen J, Alfaro G, Beh CT. Polarized exocytosis induces compensatory endocytosis by Sec4p-regulated cortical actin polymerization. PLoS Biol. 2016; 14(8):e1002534.","DOI":"10.1371\/journal.pbio.1002534"},{"key":"51540","doi-asserted-by":"crossref","unstructured":"Jensen D, Schekman R. COPII-mediated vesicle formation at a glance. J Cell Sci. 2011; 124(Pt 1):1-4.","DOI":"10.1242\/jcs.069773"},{"key":"51541","doi-asserted-by":"crossref","unstructured":"Sparber F, Scheffler JM, Amberg N. The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis. Blood. 2014; 123(2):217-227.","DOI":"10.1182\/blood-2013-08-518555"},{"key":"51542","doi-asserted-by":"crossref","unstructured":"Villasenor R, Kalaidzidis Y, Zerial M. Signal processing by the endosomal system. Curr Opin Cell Biol. 2016; 39:53-60.","DOI":"10.1016\/j.ceb.2016.02.002"},{"key":"51543","doi-asserted-by":"crossref","unstructured":"Bonifacino JS, Glick BS. The mechanisms of vesicle budding and fusion. Cell. 2004; 116(2):153-166.","DOI":"10.1016\/S0092-8674(03)01079-1"},{"key":"51544","doi-asserted-by":"crossref","unstructured":"Hutter C, Kauer M, Simonitsch-Klupp I. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood. 2012; 120(26):5199-5208.","DOI":"10.1182\/blood-2012-02-410241"},{"key":"51545","doi-asserted-by":"crossref","unstructured":"Milne P, Bigley V, Bacon CM. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood. 2017; 130(2):167-175.","DOI":"10.1182\/blood-2016-12-757823"},{"key":"51546","doi-asserted-by":"crossref","unstructured":"Shi H, He H, Cui L. Transcriptomic landscape of circulating mononuclear phagocytes in Langerhans cell histiocytosis at the single-cell level. Blood. 2021; 138(14):1237-1248.","DOI":"10.1182\/blood.2020009064"},{"key":"51547","doi-asserted-by":"crossref","unstructured":"Hogstad B, Berres ML, Chakraborty R. RAF\/MEK\/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. J Exp Med. 2018; 215(1):319-336.","DOI":"10.1084\/jem.20161881"},{"key":"51548","doi-asserted-by":"crossref","unstructured":"Annels NE, Da Costa CE, Prins FA. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med. 2003; 197(10):1385-1390.","DOI":"10.1084\/jem.20030137"},{"key":"51549","doi-asserted-by":"crossref","unstructured":"Senechal B, Elain G, Jeziorski E. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med. 2007; 4(8):e253.","DOI":"10.1371\/journal.pmed.0040253"},{"key":"51550","unstructured":"Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood. 1999; 94(12):4195-4201."},{"key":"51551","doi-asserted-by":"crossref","unstructured":"Quispel WT, Stegehuis-Kamp JA, Santos SJ. Intact IFN-gammaR1 expression and function distinguishes Langerhans cell histiocytosis from mendelian susceptibility to mycobacterial disease. J Clin Immunol. 2014; 34(1):84-93.","DOI":"10.1007\/s10875-013-9959-1"},{"key":"51552","doi-asserted-by":"crossref","unstructured":"Ismail MB, Akefeldt SO, Lourda M. High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosis. Cytokine. 2020; 126:154877.","DOI":"10.1016\/j.cyto.2019.154877"},{"key":"51553","doi-asserted-by":"crossref","unstructured":"McClain KL, Picarsic J, Chakraborty R. CNS Langerhans cell histiocytosis: common hematopoietic origin for LCH-associated neurodegeneration and mass lesions. Cancer. 2018; 124(12):2607-2620.","DOI":"10.1002\/cncr.31348"},{"key":"51554","doi-asserted-by":"crossref","unstructured":"Javadi J, Gorgens A, Vanky H. Diagnostic and prognostic utility of the extracellular vesicles subpopulations present in pleural effusion. Biomolecules. 2021; 11(11):1606.","DOI":"10.3390\/biom11111606"},{"key":"51555","doi-asserted-by":"crossref","unstructured":"Peinado H, Zhang H, Matei IR. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017; 17(5):302-317.","DOI":"10.1038\/nrc.2017.6"},{"key":"51556","doi-asserted-by":"crossref","unstructured":"El-Andaloussi S, Mager I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12(5):347-357.","DOI":"10.1038\/nrd3978"},{"key":"51557","doi-asserted-by":"crossref","unstructured":"Bigenwald C, Le Berichel J, Wilk CM. BRAF(V600E)-induced senescence drives Langerhans cell histiocytosis pathophysiology. Nat Med. 2021; 27(5):851-861.","DOI":"10.1038\/s41591-021-01304-x"},{"key":"51558","doi-asserted-by":"crossref","unstructured":"Kim SW, Kim DH, Park KS. Palmitoylation controls trafficking of the intracellular Ca(2+) channel MCOLN3\/TRPML3 to regulate autophagy. Autophagy. 2019; 15(2):327-340.","DOI":"10.1080\/15548627.2018.1518671"},{"key":"51559","doi-asserted-by":"crossref","unstructured":"Quispel WT, Stegehuis-Kamp JA, Santos SJ, Egeler RM, van Halteren AG. Activated conventional T-cells are present in Langerhans cell histiocytosis lesions despite the presence of immune suppressive cytokines. J Interferon Cytokine Res. 2015; 35(10):831-839.","DOI":"10.1089\/jir.2014.0190"},{"key":"51560","doi-asserted-by":"crossref","unstructured":"Gupta D, Wiklander OPB, Gorgens A. Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles. Nat Biomed Eng. 2021; 5(9):1084-1098.","DOI":"10.1038\/s41551-021-00792-z"},{"key":"51561","doi-asserted-by":"crossref","unstructured":"Chen G, Huang AC, Zhang W. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018; 560(7718):382-386.","DOI":"10.1038\/s41586-018-0392-8"},{"key":"51562","doi-asserted-by":"crossref","unstructured":"Serrati S, Guida M, Di Fonte R. Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma. Mol Cancer. 2022; 21(1):20.","DOI":"10.1186\/s12943-021-01490-9"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282638\/75445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282638\/75956","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11021\/75445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:42Z","timestamp":1794045822000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.282638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.282638","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,16]]}}}